Cardiac Imaging Software Market Size, Share and Trends Analysis, By Product Type (Standalone Software and Integrated Software), By Imaging Modality (Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Cardiology, and X-Ray), By Deployment Mode (On-Premise, Hybrid, and Cloud), By Procedure Type, By End-Use, and By Region, Forecast 2025-2032

Cardiac Imaging Software Market Overview and Key Insights:

The cardiac imaging software market size reached USD 688.3 million in 2024 and is expected to register a revenue CAGR of 13.5% during the forecast period. Recent advances in advanced imaging modalities such as magnetic resonance imaging (MRI), multidetector computed tomography (CT), and hybrid modalities such as positron emission tomography-CT (PET-CT) have expanded the scope of cardiovascular disease diagnostics. These modalities add to the already extensive variety of image-based diagnostic methods utilized in cardiology.

Market Drivers:

Increasing prevalence of cardiovascular diseases (CVD) is a key driver of revenue growth in the cardiac imaging software market. According to the World Heart Federation, in 2021, CVDs claimed the lives of 20.5 million people, accounting for 32% of total global mortality. Heart attacks and strokes account for 85% of all CVD mortality. More than 75 percent of CVD deaths occur in low- and middle-income nations. In the previous 30 years, the number of persons with hypertension, a key risk factor for CVD, has doubled to 1.28 billion. Hypertension kills approximately 10 million people annually– more people than any other condition and all infectious diseases combined.

Rising adoption of AI-powered imaging solutions is another key factor driving the market for cardiac imaging software. Several machine learning applications have been proposed for feature extraction and segmentation in cardiology pictures. Machine learning algorithms can be used to automatically identify lesions in coronary CTA pictures. Artificial Intelligence (AI) in cardiovascular imaging is a rapidly emerging subject with enormous potential for diagnosis and prognosis. Deep learning has helped overcome typical CMR difficulties, such as the long acquisition times required by the high-resolution requirement. Generative adversarial networks, for example, enable the synthesis of cine-like CMR pictures from real-time sequences, aiding patients who struggle with breath-holding or have arrhythmias, and therefore enhancing image quality.

On April 2025, DESKi has announced FDA approval for HeartFocus, an AI-enabled heart exam software that allows any healthcare practitioner, including beginners, to perform clinical-quality heart scans from any compatible device with just a few hours of training. The FDA also authorized DESKi’s Predetermined Change Control Plan (PCCP) for HeartFocus’ expansion potential. This paves the way for speedier collaboration with other ultrasound systems, allowing the technology to reach more patients sooner.

Market Opportunity:

Expansion of telemedicine and cloud-based imaging platforms acts as opportunities for cardiac imaging software market. Cloud PACS (Picture Archiving and Communication System) provides remote diagnostics by securely storing, accessing, and analyzing medical pictures like X-rays, MRIs, CT scans, and ultrasounds via the internet. Integrating cloud PACS with telehealth services enables patients to securely access their medical images and reports, enhancing transparency and empowering them to make healthcare decisions. It also works with telemedicine platforms, enabling healthcare providers to employ medical imaging during virtual consultations and remote monitoring. This integration enables doctors to obtain patient photos directly from the telemedicine interface, so streamlining workflows and enhancing virtual care quality.

On October 2024, TeraRecon, the industry leader in medical imaging advanced visualization, clinical AI, and workflow automation, has announced enhancements to its Intuition platform, including new best-in-class cardiac magnetic resonance (MR) medical imaging capabilities. These clinical advances are now available in all deployment modes and on the most advanced cloud infrastructure. Intuition’s vast cardiac modules improve processes and enhance diagnostic skills for common cardiac MR scenarios.

Recent Trends:

Emerging trends include AI-powered image analysis, cloud-based imaging platforms, 3D and 4D visualization, fusion imaging, and Augmented Reality (AR), and deep learning for prognostic modelling.

Virtual reality (VR) and augmented reality (AR) applications help both health care practitioners and patients learn about cardiovascular health by supplementing traditional learning techniques. Augmented reality is largely regarded as a beneficial tool in medicine, having the potential to improve diagnosis, therapy, and illness management. In medical imaging, AR provides detailed insights by superimposing digital data on imaging tests, assisting with diagnosis and therapy planning. AR is expected to continue changing medical education and training by delivering interactive, three-dimensional depiction of complex imaging data, enabling healthcare practitioners to learn advanced skills more effectively.

On February 2024, Sira Medical has received 510(k) clearance from the US Food and Drug Administration for its augmented reality preoperative surgery planning application, which offers doctors with improved imaging to help them make critical patient management decisions. Sira Medical technology was originally created at UCSF with financing from the UCSF Innovation Ventures Catalyst program and is exclusively licensed through the UCSF Office of Technology.

Restraints & Challenges:

Although AI has shown promise, there has not been enough time for methodological development and prospective clinical studies to demonstrate its superiority over human interpretations in terms of patient outcomes. Data shortages, privacy constraints, and ethical concerns all limit effective AI training. Furthermore, the absence of a unified model for the heart’s complex structure and function, as well as evolving domain knowledge, might induce heuristic biases and influence underlying assumptions during model building.

Product Type Segment Insights and Analysis:

Based on the product type, the cardiac imaging software market is segmented into standalone software and integrated software.

Integrated software segment contributed the fastest growth rate during the forecasted period. It has been sub-segmented into PACS (Picture Archiving and Communication Systems), RIS (Radiology Information Systems), and CVIS (Cardiovascular Information Systems). Integrated cardiovascular imaging is the ideal utilization of numerous imaging modalities to gain complementary information regarding heart disorders, assisting in diagnosis, determining aetiology, and prognosis, with the goal of successfully directing clinical decision making. While modality-centric expertise has been the primary driver of advancements in each modality, it has also contributed to imagers working in silos, resulting in inadequate inter-modality coordination and collation of pertinent patient care information.

On June 2024, RamSoft, a global leader in cloud-based RIS/PACS radiology solutions, and RADPAIR, a healthcare technology innovator, have announced the addition of AI-powered radiology report production to the OmegaAI platform. This cooperation represents a significant step forward in AI-driven enterprise imaging by merging RamSoft’s OmegaAI, a PACS/RIS/VMA platform, with RADPAIR’s cutting-edge Gen AI platform for automated report generation. Both solutions have zero-footprint, with a single browser-based interface for image viewing and reporting.

Imaging Modality Segment Insights and Analysis:

Based on the imaging modality, the cardiac imaging software market is segmented into ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), nuclear cardiology, and X-Ray.

Ultrasound segment contributed the largest market share in 2024. The functional cardiac assessment of cardiovascular illness now includes cardiac ultrasonography, often known as echocardiography. A more accurate visual representation of cardiac anatomy is now possible because to three-dimensional imaging. Because echocardiography is non-invasive, user-friendly, and offers high-resolution imaging and real-time feedback, it has emerged as the preferred modality for the initial evaluation of heart illness. While transoesophageal echocardiography is utilized to evaluate posterior cardiac structures and valvular disorders, transthoracic echocardiography has emerged as the dominant technique for quantifying heart chambers.

On June 2023, UltraSight, a leader in digital health that is using AI to revolutionize cardiac imaging, announced that the FDA has approved their AI-powered ultrasound guidance solution. More widespread detection of heart disease and easier access to cardiac monitoring for patients are made possible by the UltraSight real-time AI guidance software, which can help healthcare providers without sonography experience obtain cardiac ultrasound images at the point of care in a variety of settings. Hospital employees will be able to progress patient triage and treatment with greater clinical certainty and efficiency owing to UltraSight’s solution.

Procedure Type Segment Insights and Analysis:

Based on the procedure, the cardiac imaging software market is segmented into diagnostic procedures, interventional procedures, and monitoring procedures.

Diagnostic procedures segment contributed the largest market share in 2024. With 3-D volume rendering techniques, high-quality images may be generated that provide a realistic anatomical representation of the heart and vessels, allowing physicians and care providers to better examine anatomical structures and morphological abnormalities. Over the last decade, three-dimensional (3-D) imaging has rapidly become a key component of the visualization tools used in a wide range of radiology diagnostic procedures. The latest generation of multi-detector computed tomography (CT) and magnetic resonance imaging (MRI) scanners can capture high-resolution dynamic images of the heart in a single breath-hold.

On May 2024, Siemens Healthineers has announced new cardiology applications with artificial intelligence for the Acuson Sequoia ultrasound system, as well as a new 4D transesophageal (TEE) transducer for cardiology exams. These cardiology capabilities, along with the improved transducer, complete the Acuson Sequoia as a full-featured ultrasound system for regional hospitals, radiology, and vascular clinics that operate on a shared service paradigm. Instead of using a general imaging system and a dedicated cardiology system, this device does radiology, obstetrics/gynecology, and cardiology exams with a single ultrasound system.

Geographical Outlook:

Cardiac imaging software market is strategically segmented by geography to provide a comprehensive understanding of regional market dynamic. Discover demand analysis, emerging trends, and growth opportunities shaping market performance across different region and countries.

North America Cardiac Imaging Software Market:

North America is registered to have highest market share in cardiac imaging software market in 2024. This is mainly driven by increasing prevalence of cardiovascular diseases and rising adoption of AI-powered imaging solutions. According to the US Centres for Disease Control and Prevention (CDC), heart disease is the top cause of death among men, women, and people of all racial and cultural backgrounds. Every 33 seconds, one person dies from cardiovascular disease. In 2022, 702,880 individuals died of heart disease. That is the equivalent of one out of every five deaths.

On April 2025, Medis Medical Imaging, the premier cardiac imaging software business, has announced that the FDA has cleared the latest version of their breakthrough Medis QFR in the United States. Medis QFR, which uses AI and Deep Learning, is a safe and wire-free software solution for assessing angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR, which has been shown to improve procedure efficiency, is now FDA cleared in its most recent version, 3.0.

Asia Pacific Cardiac Imaging Software Market:

Asia Pacific is expected to register the fastest growth rate during the forecasted period, driven by expansion of telemedicine and cloud-based imaging platforms and development of personalized and precision cardiology tools. Japan and Korea have a strong base for medical informatization and are gradually embracing telemedicine. The Korean government permits the use of telemedicine during public health emergencies. China has established economy-wide healthcare networks, telemedicine cloud service platforms, and video cloud service platforms. Hospitals above tier 2 can provide telemedicine services via Internet or private networks, and all state-level poverty-stricken county hospitals now have full telemedicine coverage.

On May 2024, Circle Cardiovascular Imaging Inc. and inHEART Inc. have signed a global distribution agreement, allowing Circle to promote and market inHEART’s advanced, AI-enabled digital twin of the heart via Circle’s global sales network. This collaboration will enable inHEART to rapidly expand global commercialization of their procedural planning software system for image-guided cardiac ablations.

Europe Cardiac Imaging Software Market:

Europe is expected to have considerable market share in 2024. According to the British Heart Foundation, in the UK, about 7.6 million people have heart and circulation illnesses, including over 4 million men and 3.6 million women. In the UK, heart and circulation disorders affect approximately twice as many individuals as cancer and Alzheimer’s combined. Heart and circulatory illnesses account for around 26% of all deaths in the UK. Every year, over 49,000 persons under 75 in the UK die from heart and circulation disorders.

On June 2024, AGFA HealthCare has announced a substantial new agreement with Alliance Medical to install an innovative cloud-based solution across all of Alliance Medical’s UK campuses. This cutting-edge method, powered by the AGFA HealthCare Enterprise Imaging Platform, is intended to help Alliance Medical UK’s Future Unified Diagnostic Information System (FUDIS) initiative. This initiative intends to streamline the whole patient journey, resulting in a strong and long-lasting cooperation between AGFA HealthCare and Alliance Medical.

Competition Analysis:

The cardiac imaging software market is characterized by a fragmented structure, with several players competing across various segments and regions. list of major players included in the cardiac imaging software market report are:

• Koninklijke Philips NV
• Siemens Healthineers
• Medis Medical Imaging Systems B.V.
• Circle Cardiovascular Imaging Inc.
• GE HealthCare
• Cleerly, Inc.
• Ultromics Limited
• CArdiac Simulation & Imaging Software
• com
• NeoSoft, LLC
• Visage Imaging, Inc.
• Canon Medical Systems Corporation
• FUJIFILM Healthcare Americas Corporation
• Scintica Instrumentation, Inc.
• Shimadzu Corporation

Strategic Developments in Cardiac Imaging Software Market:

• In April 2024, Exo, a medical imaging software and hardware firm, reported that its FDA-cleared heart and lung artificial intelligence (AI) apps are now accessible on Exo Iris, the company’s high-performance portable ultrasound system. With inexpensive, AI-powered medical imaging in a pocket-sized device, caregivers may get answers right away to speed diagnosis and build novel therapy paths for heart failure patients at the point of care.
• In February 2024, UltraSight, a digital health pioneer redefining cardiac imaging with the power of artificial intelligence, has announced a collaboration with SELVAS Healthcare, a Korean-based global digital healthcare firm with revolutionary technologies in medical device manufacturing and software. This new joint venture marks the start of UltraSight’s real-time AI guidance technology in Asia, commencing with the regulatory approval procedure that could lead to ultimate commercialization and distribution in Korea and the Southeast Asian market.
• In November 2023, Elucid, a renowned medical technology firm that offers clinicians AI-powered imaging analysis tools to diagnose cardiovascular illness, revealed that it has raised USD 80 million in Series C funding. Elevage Medical Technologies led the round, which included participation from industry strategics and existing investors. With this funding, Elucid is ready to build on the previous year’s success and expand its commercialization efforts to give important information to clinicians and patients fighting heart disease.

Key Advantages for Stakeholders:

Navistrat Analytics’ industry report provides an in-depth quantitative analysis of various market segments, historical and current trends, market forecasts, and dynamics within the global market. The historical years covered in this report are 2022 to 2023, with 2024 serving as the base year for market size calculations. The forecast period extends from 2025 to 2032.

The report includes an executive summary and a comprehensive overview of market drivers, restraints, opportunities, and challenges (DROC), along with insights into regulatory standards. It features detailed analyses such as PORTER’s Five Forces, SWOT, and PESTLE, as well as assessments of technological trends and the competitive landscape.

PORTER’s Five Forces analysis helps stakeholders evaluate the impact of new entrants, competitive rivalry, supplier power, buyer power, and substitution threats, enabling them to assess the level of competition and the attractiveness of the global market. The competitive landscape provides stakeholders with a clear understanding of the current market positions of key players, offering valuable insights into their competitive environment.

Scope And Key Highlights Of The Cardiac Imaging Software Market Report:

The Cardiac Imaging Software market report offers a detailed analysis of market size, including historical revenue (in USD Million) data for 2022-2023 and revenue forecasts for 2025-2032 across the following segments:

• Product Type Outlook (Revenue, USD Million; 2022-2032)
  • Standalone Software
    • Advanced Visualization Software
    • Image Analysis Software
  • Integrated Software
    • PACS (Picture Archiving and Communication Systems)
    • RIS (Radiology Information Systems)
    • CVIS (Cardiovascular Information Systems)

• Imaging Modality Outlook (Revenue, USD Million; 2022-2032)
  •  Ultrasound
    • Transthoracic Echocardiography (TTE)
    • Transesophageal Echocardiography (TEE)
    • Stress Echocardiography
    • 3D Echocardiography
  • Computed Tomography (CT)
    • Calcium-score screening heart scan
    • Coronary CT angiography (CTA)
    • Total body CT scan
  • Magnetic Resonance Imaging (MRI)
    • Cardiac MRI
    • MR Angiography
  • Nuclear Cardiology
    • Single Photon Emission Computed Tomography (SPECT)
    • Positron Emission Tomography (PET)
  • X-ray
    • Digital Radiography
    • Fluoroscopy

• Technology Outlook (Revenue, USD Million; 2022-2032)
  • On-Premise
  • Hybrid
  •  Cloud
    • Public
    • Private

• Procedure Outlook (Revenue, USD Million; 2022-2032)
  • Diagnostic Procedures
    • Non-invasive Imaging
    • Invasive Imaging
  • Interventional Procedures
    • Pre-procedural Planning
    • Intra-procedural Imaging
    • Post-procedural Assessment
  • Monitoring Procedures
    • Routine Check-ups
    • Chronic Disease Management

• End-Use Outlook (Revenue, USD Million; 2022-2032)
  • Hospitals
    • Academic
    • Community
    • Private
  • Diagnostic Centers
    • Independent Imaging Centers
    • Cardiac Imaging Centers

• Regional Outlook (Revenue, USD Million; 2022-2032)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Benelux
    • Nordic Countries
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Oceania
    • ASEAN Countries
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Turkey
    • Rest of MEA

Frequently Asked Questions (FAQ) about the Cardiac Imaging Software market report